Sotatercept as a next-generation therapy for pulmonary arterial hypertension: insights from the STELLAR trial

Cardiovasc Res. 2023 Dec 19;119(16):e155-e157. doi: 10.1093/cvr/cvad121.

Author

Grzegorz Kopeć^{1

2}

Affiliations

¹ Pulmonary Circulation Centre, Department of Cardiac and Vascular Diseases, Jagiellonian University Medical College, Prądnicka 80, 31-202 Kraków, Poland.
² Department of Cardiac and Vascular Diseases, John Paul II Hospital in Krakow, Prądnicka 80, 31-202 Kraków, Poland.

PMID: 37584249
DOI: 10.1093/cvr/cvad121

No abstract available

Keywords: Activin; Biomarkers; Pulmonary arterial hypertension; Smad protein; TGF beta superfamily protein.

MeSH terms

Familial Primary Pulmonary Hypertension
Humans
Protein Serine-Threonine Kinases
Pulmonary Arterial Hypertension* / diagnosis
Pulmonary Arterial Hypertension* / drug therapy
Recombinant Fusion Proteins
Transforming Growth Factor beta

Substances

ACE-011
Protein Serine-Threonine Kinases
Recombinant Fusion Proteins
Transforming Growth Factor beta